Skip to main content

Table 2 KEGG pathway enrichment results of Neuroactive ligand-receptor interaction and Cytokine-cytokine receptor interaction

From: Gene regulatory networks analysis of muscle-invasive bladder cancer subtypes using differential graphical model

 

Cytokine-cytokine receptor interaction

Neuroactive ligand-receptor interaction

 

p_value

p_adjust

count

p_value

p_adjust

count

PI

1.73E-10

1.49E-08

47

1.42E-05

3.31E-04

40

PL

-

-

-

3.12E-05

3.37E-03

22

PN

-

-

-

4.98E-19

1.45E-16

86

PB

4.33E-31

1.26E-28

103

2.76E-04

2.77E-03

56

IL

2.69E-04

2.20E-03

17

4.83E-04

3.67E-03

18

IN

3.96E-06

1.02E-04

46

6.73E-18

1.91E-15

76

IB

2.36E-04

6.14E-03

24

-

-

-

LN

4.14E-04

8.96E-03

39

2.74E-15

7.96E-13

70

LB

1.57E-26

4.61E-24

89

7.01E-05

6.65E-04

52

NB

1.44E-14

1.05E-12

76

1.25E-19

3.65E-17

93

  1. Note: The count means that the number of differential genes between two subtypes annotated in the pathway